Virginia Commonwealth University at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Virginia Commonwealth University brings 3 presentations to ObesityWeek 2026 in National Harbor. Its sessions cover obesity treatment and food policy for families, from medication to home-based care for children. They include the long-term effectiveness of phentermine in the LEAP trial and parents' views on upcoming SNAP limits on sweetened beverages in Virginia.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Virginia Commonwealth University Richmond, VA | |
Public research university in Richmond, Virginia, with a school of medicine. | Session Mon Nov 16 8:30am–9:30am LEAP Trial: Long-Term Effectiveness of the Obesity Medication Phentermine Presents results of LEAP, the first 24-month placebo-controlled trial of the widely used obesity drug phentermine, covering effectiveness, heart risk and safety. Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthObesity pharmacotherapy and drug developmentChronic disease and obesity complications Poster Mon Nov 16 2:30pm–3:30pm Talk Mon Nov 16 5:45pm–6:00pm |
Find decision makers at Virginia Commonwealth University
Tell us what you sell and we’ll find the people at Virginia Commonwealth University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction